How long does it take for sparsentan to be effective? What is the effect?

IgA nephropathy (IgAN) is a rare kidney disease that causes kidney failure and has always attracted much attention. Among the various treatment options for this disease, sparsentan (sparsentan) brings new hope to patients with its unique therapeutic mechanism. Spaxentan is a once-daily oral medication unique in its ability to selectively target two key pathways in IgAN disease progression - endothelin-1 and angiotensin II. This makes spaxentan the first and only non-immunosuppressive drug approved to treat this disease.

Interim results from the ongoing Phase 3 PROTECT head-to-head trial provide us with strong evidence regarding the therapeutic efficacy of sparsentane. Sparsentan demonstrated rapid and sustained effects in reducing proteinuria compared with the active comparator, irbesartan. This effect is not only statistically significant, but also significant in clinical practice. Specifically, sparsentan can reduce urinary protein by 49.8%, which is more than three times that of irbesartan (15.1%).

In the interim evaluation of the PROTECT study, sparsentane was confirmed to be well tolerated and its safety profile has been consistent across all clinical trials conducted to date. This provides strong support for the long-term application of sparsentane in the treatment of IgAN.

However, the question of how long sparsentan needs to be taken to see significant effects depends on the patient's specific condition and constitution. Generally speaking, the treatment of sparsentane is a continuous process. Patients need to take the medicine on time and in the right amount under the guidance of a doctor, and undergo regular examinations to evaluate the treatment effect.

In general, as a new drug for the treatment of IgAN, sparsentan has a rapid and sustained effect in reducing proteinuria, as well as good tolerability and safety, bringing a new treatment option to IgAN patients. However, the specific treatment effect and treatment time still need to be determined according to the patient's specific situation.